NCT01513330

Brief Summary

The purpose of the study is to evaluate leakage of a newly developed ostomy product compared to standard care in subjects with colostomies. Subjects will be asked to use each test product for 2 weeks - in total, the study period is 4 weeks and the hypothesis is to show that the newly developed ostomy product is significantly better to reduce leakage compared to standard care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
122

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Nov 2011

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 10, 2012

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 20, 2012

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2012

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

January 9, 2014

Completed
Last Updated

January 9, 2014

Status Verified

November 1, 2013

Enrollment Period

7 months

First QC Date

January 10, 2012

Results QC Date

August 6, 2013

Last Update Submit

November 21, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Degree of Leakage. Each Baseplate Can Have a Score From 0-24 Points Were 0 is the Best Possible Outcome (No Leakage) and 24 Points is the Worst Possible Outcome (Full Plate Leakage)

    Degree of leakage will be measured by a 25-point leakage scale (no leakage or up till 24 points of leakage), developed by Coloplast A/S. The subjects receive Petri dishes with pre-printed leakage scale on. The subject will place the Petri dish above the used baseplate and indicate where on the baseplate output appears. This is done by ticking of each area on the scale indicating the area of leakage.

    14 days

Study Arms (2)

First Standard Care, then SenSura Mio

EXPERIMENTAL

Subjects first test Standard Care (Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima) and after cross-over SenSura Mio

Device: SenSura MioDevice: Standard Care

First SenSura Mio, then Standard Care

EXPERIMENTAL

Subjects first test SenSura Mio and after cross-over Standard Care(Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima)

Device: SenSura MioDevice: Standard Care

Interventions

Ostomy product - 1 piece closed bag

First SenSura Mio, then Standard CareFirst Standard Care, then SenSura Mio

Ostomy product 1 piece closed bags. Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima.

First SenSura Mio, then Standard CareFirst Standard Care, then SenSura Mio

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Have given written informed consent.
  • Be at least 18 years of age and have full legal capacity.
  • Have experienced leakage under the base plate at least once a week over the last two weeks.
  • Be able to handle the bags themselves or with help from caregiver (e.g. spouse).
  • Have a colostomy with a diameter between 20 and 45 mm.
  • Have had their ostomy for at least three months.
  • Currently use a 1-piece flat product with closed bag.
  • Use minimum 1 product per day.
  • Be suitable for participation in the investigation and for using a standard adhesive, flat base plate (evaluated by investigator).

You may not qualify if:

  • Use irrigation during the study (flush the stoma with water).
  • Currently receiving or have within the past 2 months received radio- and/or chemotherapy.
  • Currently receiving or have within the past month received local or systemic steroid treatment in the peristomal area.
  • Are pregnant or breastfeeding.
  • Participating in other interventional clinical investigations or have previously participated in this investigation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Publicare

Cologne, Køln, Germany

Location

Results Point of Contact

Title
Director of Clinical Trials
Organization
Coloplast A/S

Study Officials

  • Wenche Sundberg, stoma nurse

    Diakonhjemmet Sykhus, Oslo

    PRINCIPAL INVESTIGATOR
  • Merete Bjørke, Stoma Nurse

    St. Olavs Hopsital

    PRINCIPAL INVESTIGATOR
  • Vigids Dagsland, Stoma Nurse

    Haugesund Sykhus

    PRINCIPAL INVESTIGATOR
  • Randi Melum, Stoma Nurse

    St. Olavs Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2012

First Posted

January 20, 2012

Study Start

November 1, 2011

Primary Completion

June 1, 2012

Study Completion

August 1, 2012

Last Updated

January 9, 2014

Results First Posted

January 9, 2014

Record last verified: 2013-11

Locations